Lessee, Operating Lease, Liability, to be Paid of VERTEX PHARMACEUTICALS INC / MA from 31 Mar 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 31 Mar 2019 to 31 Dec 2024.
  • VERTEX PHARMACEUTICALS INC / MA Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Dec 2024 was $2,739,200,000, a 528% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $2,739,200,000 +$2,303,100,000 +528% 31 Dec 2024 10-K 13 Feb 2025 2024 FY
Q3 2024 $2,794,800,000 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q4 2023 $436,100,000 -$55,200,000 -11% 31 Dec 2023 10-K 15 Feb 2024 2023 FY
Q4 2022 $491,300,000 +$9,100,000 +1.9% 31 Dec 2022 10-K 10 Feb 2023 2022 FY
Q4 2021 $482,200,000 +$11,791,000 +2.5% 31 Dec 2021 10-K 09 Feb 2022 2021 FY
Q4 2020 $470,409,000 +$355,104,000 +308% 31 Dec 2020 10-K 11 Feb 2021 2020 FY
Q4 2019 $115,305,000 31 Dec 2019 10-K 13 Feb 2020 2019 FY
Q3 2019 $88,023,000 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $85,425,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $88,951,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.